MENU
SLN
Stock ticker:
PRICE
CHANGE
CAPITALIZATION
Silence Therapeutics (SLN) Ownership - Who owns Silence Therapeutics?
Profile
Industry
N/A
Address
72 Hammersmith Road
Phone
+44 2034576900
Employees
109
Web
https://www.silence-therapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
806.56M
P/E Ratio
N/A
Total Cash
149.59M
Projected Growth
N/A
Total Debt
184K
Revenue
17.9M
Risk (Beta)
1.29
Dividend Yield
N/A
Total Cash/Share
3.20
Total Debt/Equity
N/A
Revenue/Share
0.57 USD as % of share price
Fundamentals
SLN
Capitalization
807M
P/E Ratio
N/A
Risk (Beta)
1.29
Dividend Yield
N/A
Total Cash
150M
Total Cash/Share
3.20
Total Debt
184K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.57%
Revenue
17.9M
ROE
N/A
Book Value
113M
P/B Ratio
5.66
Cash Flow
N/A
Earnings
-0.98
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
7.02M
Current Ratio
9.83
Current Revenue Per Employee
5486.24
Dividends Per Share - Security
N/A
EBITDA
-47.64M
Float
N/A
Float - Current
N/A
Gross Income Margin
-341.14
Revenue To Assets
-28.51
Shares Held By Institutions
539M
Shares Outstanding - Current
46.8M
Total Liabilities
76.1M
Total Volume MTD
N/A
Value
N/A
Gain YTD
4.030
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
72 Hammersmith Road
Phone
+44 2034576900
Employees
109
Web
https://www.silence-therapeutics.com